As the number of childhood cancer survivors grows, more attention on the identification and management of late effects, such as neurocognitive decline, is needed. This study, investigating treatment with central nervous system (CNS) stimulants for cognitive changes related to pediatric cancer treatment, confirmed a common concern. How should neurocognitive decline be measured and followed up after cancer therapy? Multiple pediatric standardized cognitive tests are available, but there is no consensus on an efficient way to measure the most common areas of decline, specifically impaired concentration, memory, and mental processing speed. The authors' report recognized 12 pediatric patients at risk for cognitive dysfunction, of whom 3 tested positive for early neurocognitive deficits using 3 subscales of the Wechsler Intelligence Scale for Children—III (WISC-III), which measure working verbal memory (Digit Span), mental processing speed (Symbol Search), and psychomotor speed (Coding). To predict the expected level of performance on WISC-III subscales, the patients' IQ was estimated using the Wide Range Achievement Test—3 reading subtest. Patients were treated with long-acting CNS stimulants and followed up serially using the WISC-III subscales.
American Cancer Society. (2006). Childhood cancer: Late effects of cancer treatment. Retrieved June 4, 2008, from http://www.cancer.org/docroot/CRI/content/CRI_2_6x_Late_Effects_of_Childhood_Cancer.asp
2.
Armstrong, F., Blumberg, M., & Toledano, S. (1999). Neurobehavioral issues in childhood cancer. School Psychology Review, 28, 194-203.
3.
Briere, M., Scott, J.G., Mcnall-Knapp, R.Y., & Adams, R.L. (2007). Cognitive outcome in pediatric brain tumor survivors: Delayed attention deficit at long term follow-up. Pediatric Blood and Cancer, 50, 337-340.
4.
Brouwers, P., & Poplack, D. (1990). Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: Association with attention deficits. American Journal of Pediatric Hematology/Oncology, 12, 174-181.
5.
Brown, R.T., Madan-Swain, A., Pais, R., Lambert, R.G., Sexson, S., & Ragab, A. (1992). Chemotherapy for acute lymphocytic leukemia: Cognitive and academic sequelae. Journal of Pediatrics, 121, 885-889.
6.
Brown, R.T., Madan-Swain. A., Walco, G.A., Cherrick, I., Levers, C.E., Conte, P.M., et al. (1998). Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. Journal of Pediatric Psychology, 23, 333-340.
7.
Dennis, M., Hetherington, C.R., & Spiegler, B. (1998). Memory and attention after childhood brain tumors . Medical and Pediatric Oncology Supplement, 1, 25-33.
8.
Espy, K.A., Moore, I.M., Kaufmann, P.M., Kramer, J.H., Matthay, K., & Hutter, J.J. (2001). Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: Prospective study. Journal of Pediatric Psychology, 26, 1-9.
9.
Gamis, A.S., & Nesbit, M.E. (1991). Neuropsychologic (cognitive) disabilities in long-term survivors of childhood cancer. Pediatrician, 18, 11-19.
10.
Glauser, T.A., & Packer, R.J. (1991). Cognitive deficits in long-term survivors of childhood brain tumors. Child's Nervous System, 7, 2-12.
11.
Haupt, R., Fears, T.R., Robison, L.L., Mills, J.L., Nicholson, H.S., Zeltzer, L.K., et al. (1994). Educational attainment in long-term survivors of acute lymphoblastic leukemia. Journal of the American Medical Association, 272, 1427-1432.
12.
Mostow, E.N., Byrne, J., Connelly, R.R., & Mulvihill, J.J. (1991). Quality of life in long-term survivors of CNS tumors of childhood and adolescence. Journal of Clinical Oncology, 9, 592-599.
13.
Mulhern, R.K., Hancock, J., Fairclough, D., & Kun, L. (1992). Neuropsychological status of children treated for brain tumors: A critical review and integrative analysis. Medical and Pediatric Oncology, 20, 181-191.
14.
Mulhern, R.K., Kepner, J.L., Thomas, P.R., Armstrong, D., Friedman, H.S., & Kun, L.E. (1998). Neuropsychological functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal radiation: A pediatric oncology group study. Journal of Clinical Oncology, 16, 1723-1728.
15.
Mulhern, R.K., Wasserman, A.L., Fairclough, D., & Ochs, J. (1988). Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation. Journal of Clinical Oncology, 6, 315-320.
16.
Mulhern, R.K., White, H.A., Glass, J.O., Kun, L.E., Leigh, L., Thompson, S.J., et al. (2004). Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. Journal of the International Neuropsychological Society, 10, 180-190.
17.
Palmer, R.J., Gajjar, A., Reddick, W.E., Glass, J.O., Kun, L.E., Wu, S., et al. (2003). Predicting intellectual outcome among children treated 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology, 17, 548-555.
18.
Palmer, S.L., Goloubeva, O., Reddick, W.E., Glass, J.O., Gajjar, A., Kun, L., et al. (2001). Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. Journal of Clinical Oncology, 19, 2302-2308.
19.
Phipps, S., Dunavant, M., Srivastava, D.K., Bowman, L., & Mulhern, R. (2000). Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. Journal of Clinical Oncology, 18, 1004-1011.
20.
Ris, M.D., Packer, R., Goldwein, J., Jones-Wallace, D., & Boyett, J.M. (2001). Intellectual outcomes after reduce-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A children's cancer group study. Journal of Clinical Oncology, 19, 3470-3476.
21.
Robison, L.L., Green, D.M., Hudson, M., Meadows, A.T., Mertens, A.C., Packer, R.J., et al. (2005). Long-term outcomes of adult survivors of childhood cancer. Cancer, 104, 2557-2564.
22.
Rodgers, J., Horrocks, J., Britton, P.G., & Kernahan, J. (1999). Attention ability among survivors of leukemia . Archives of Disease in Childhood, 80, 318-323.
23.
Roman, D.D., & Sperduto, P.W. (1995). Neuropsychological effects of cranial radiation: Current knowledge and future directions. International Journal of Radiation Oncology, Biology, Physics, 31, 983-998.
24.
Rubenstein, C.L., Varni, J.W., & Katz, E.R. (1990). Cognitive functioning in long-term survivors of childhood leukemia: A prospective analysis. Developmental and Behavioral Pediatrics, 11, 301-305.
25.
Sattler, J.M. (2001). Assessment of children: Cognitive applications (4th ed.). San Diego, CA: Jerome M. Sattler.
26.
Schatz, J., Kramer, J.H., Albin, A., & Matthay, K.K. (2000). Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology, 14, 89-200.
27.
Spiegler, B.J., Kennedy, K., Maze, R.Greenberg, M.L., Weitzman, S., Hitzler, J.K., et al. (2006). Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate . Journal of Clinical Oncology, 24, 3858-3864.
28.
Spreen, O., & Strauss, E. (1998). A compendium of neuropsychological tests: Administration, norms, and commentary (2nd ed.). New York: Oxford University Press.
29.
Thompson, S.J., Leigh, L., Christensen, R., Xiong, X., Kun, L.E., Heideman, R.L., et al. (2001). Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. Journal of Clinical Oncology, 19, 1802-1808.
30.
Wechsler, D. (1991). Wechsler Intelligence Scale for Children (3rd ed.). New York: Psychological Corporation.
31.
Zeltzer, L.K., Chen, E., Weiss, R., Guo, M.D., Robison, L.L., Meadows, A.T., et al. (1997). Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: A Cooperative Children's Cancer Group and National Institutes of Health study . Journal of Clinical Oncology, 15, 547-556.
